Mid-Treatment FDG-PET in HPV-Related Oropharyngeal Squamous Cell Carcinoma: Is It a Gateway to the Use of Adaptive Radiotherapy and Immunotherapy in Viral Induced Cancers and Is Abscopal Effect at Play